Showing 121-130 of 1006 results for "".
The Power of the Abandoned Cart
https://modernaesthetics.com/ma-issues-index/2020-nov-dec/the-power-of-the-abandoned-cart/34972/A simple tool could reinvigorate your marketing efforts.Board Forum | Hack Your Practice: Save Time and Money
https://modernaesthetics.com/ma-issues-index/2018-may-june/board-forum-hack-your-practice-save-time-and-money/34117/Six Considerations for Practice Success Amid COVID-19
https://modernaesthetics.com/topics/practice-development/six-considerations-for-practice-success-amid-covid-19/34926/Tips for building for success now and in the future.Two Types of Tax-Advantaged Benefit Plans: Why Aesthetic Practices Should Consider Both
https://modernaesthetics.com/topics/practice-development/two-types-of-tax-advantaged-benefit-plans-why-aesthetic-practices-should-consider-both/35155/A look at ways to reduce taxes an increase retirement savingsTax Diversification
https://modernaesthetics.com/topics/practice-development/tax-diversification/35251/An essential strategy for long-term wealth management.Buying Devices: Look Before You Leap
https://modernaesthetics.com/topics/practice-development/buying-devices-look-before-you-leap-part-2-dollars-and-good-sense/35217/Part 2: Dollars and Good SenseComing & Going: March/April 2020
https://modernaesthetics.com/ma-issues-index/2020-mar-apr/coming-going-marchapril-2020/34886/Upneeq from RVL Pharmaceuticals
https://modernaesthetics.com/ma-issues-index/2023-july-aug/upneeq-from-rvl-pharmaceuticals/35290/2020’s Top 5 Cosmetic Surgical and Minimally Invasive Procedures
https://modernaesthetics.com/ma-issues-index/2021-may-june/2020s-top-5-cosmetic-surgical-and-minimally-invasive-procedures/35033/The Dermatology and Aesthetics Mergers and Acquisitions Market: Reflecting on Trends, Looking ahead
https://modernaesthetics.com/ma-issues-index/2025-mar-apr/the-dermatology-and-aesthetics-mergers-and-acquisitions-market-reflecting-on-trends-looking-ahead/36070/As we look ahead to 2025, dermatology and aesthetic practice owners are asking a key question: What lies ahead for practice valuations and M&A opportunities?